"Naloxone" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A specific opiate antagonist that has no agonist activity. It is a competitive antagonist at mu, delta, and kappa opioid receptors.
| Descriptor ID |
D009270
|
| MeSH Number(s) |
D03.132.577.249.706 D03.605.497.750 D03.633.400.686.750 D04.615.723.795.706
|
| Concept/Terms |
MRZ-2593- MRZ-2593
- MRZ 2593
- MRZ2593
- MRZ 2593-Br
- MRZ 2593 Br
- MRZ 2593Br
|
Below are MeSH descriptors whose meaning is more general than "Naloxone".
Below are MeSH descriptors whose meaning is more specific than "Naloxone".
This graph shows the total number of publications written about "Naloxone" by people in this website by year, and whether "Naloxone" was a major or minor topic of these publications.
View timeline visualization
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 2 | 1 | 3 |
| 1995 | 0 | 7 | 7 |
| 1996 | 1 | 8 | 9 |
| 1997 | 5 | 6 | 11 |
| 1998 | 1 | 2 | 3 |
| 1999 | 4 | 1 | 5 |
| 2000 | 0 | 4 | 4 |
| 2001 | 3 | 2 | 5 |
| 2002 | 1 | 5 | 6 |
| 2003 | 6 | 10 | 16 |
| 2004 | 3 | 4 | 7 |
| 2005 | 3 | 5 | 8 |
| 2006 | 2 | 2 | 4 |
| 2007 | 3 | 2 | 5 |
| 2008 | 0 | 2 | 2 |
| 2009 | 2 | 9 | 11 |
| 2010 | 4 | 7 | 11 |
| 2011 | 6 | 7 | 13 |
| 2012 | 3 | 3 | 6 |
| 2013 | 4 | 5 | 9 |
| 2014 | 5 | 4 | 9 |
| 2015 | 4 | 2 | 6 |
| 2016 | 10 | 8 | 18 |
| 2017 | 9 | 9 | 18 |
| 2018 | 11 | 7 | 18 |
| 2019 | 11 | 8 | 19 |
| 2020 | 4 | 13 | 17 |
| 2021 | 6 | 20 | 26 |
| 2022 | 2 | 20 | 22 |
| 2023 | 3 | 17 | 20 |
| 2024 | 13 | 4 | 17 |
Below are the most recent publications written about "Naloxone" by people in Profiles.
-
Agent-Based Model of Combined Community- and Jail-Based Take-Home Naloxone Distribution. JAMA Netw Open. 2024 Dec 02; 7(12):e2448732.
-
An autonomous implantable device for the prevention of death from opioid overdose. Sci Adv. 2024 Oct 25; 10(43):eadr3567.
-
Bending the Overdose Curve - Still Not Enough. N Engl J Med. 2024 Sep 19; 391(11):1052-1053.
-
A mixed methods study to inform fatal overdose prevention in San Diego, California: Perspectives from people who use drugs. Int J Drug Policy. 2024 Nov; 133:104577.
-
Racialized environments and syringe services program implementation: County-level factors. Drug Alcohol Depend. 2024 Oct 01; 263:112430.
-
Increases in housing rules and surveillance during COVID-19: impacts on overdose and overdose response in a community-based cohort of sex workers who use drugs in Vancouver, BC. Harm Reduct J. 2024 08 22; 21(1):153.
-
Fentanyl harm reduction strategies among Latinx communities in the United States: a scoping review. Harm Reduct J. 2024 08 16; 21(1):150.
-
Naloxone and Patient Outcomes in Out-of-Hospital Cardiac Arrests in California. JAMA Netw Open. 2024 Aug 01; 7(8):e2429154.
-
Investigating the complexity of naloxone distribution: Which policies matter for pharmacies and potential recipients. J Health Econ. 2024 Sep; 97:102917.
-
How Should Harm Reduction Be Included in Care Continua for Patients With Opioid Use Disorder? AMA J Ethics. 2024 Jul 01; 26(7):E562-571.